Pfizer Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2020
Total Assets: $154.23B
Liabilities Breakdown FY2020
Total Liabilities: $90.76B
Asset Breakdown
Total Assets: $154.23B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.79B | 1.2% |
| Accounts Receivable | $7.91B | 5.1% |
| Inventory | $8.02B | 5.2% |
| Property, Plant & Equipment | $13.75B | 8.9% |
| Goodwill | $49.56B | 32.1% |
| Intangible Assets | $28.34B | 18.4% |
| Other Assets | $44.87B | 29.1% |
Liabilities Breakdown
Total Liabilities: $90.76B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.28B | 4.7% |
| Long-Term Debt | $37.13B | 40.9% |
| Other Liabilities | $49.34B | 54.4% |